| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |